Anna Rudvik

RenalMetabolism, BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.

Journal: Circulation
Published: May 15, 2026

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

Journal: Circulation
Published: May 15, 2026

Pharmacokinetics, Disposition, and Biotransformation of Laroprovstat in Humans: In Vivo and In Vitro Evaluations.

Pharmacokinetics, Disposition, and Biotransformation of Laroprovstat in Humans: In Vivo and In Vitro Evaluations.

Journal: Journal of clinical pharmacology
Published: October 13, 2025

Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.

Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.

Journal: International journal of cardiology
Published: June 21, 2022

Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting.

Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 15, 2022

Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial.

Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial.

Journal: Clinical and translational science
Published: February 18, 2022

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.

Journal: Nature communications
Published: October 23, 2018

Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough.

Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough.

Journal: BMC medical research methodology
Published: February 10, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026